Creatine Kinase Reagent Market

Creatine Kinase Reagent Market Overview (2022 to 2032)

The global creatine kinase reagent market was valued at around USD 296.2 Million at the end of 2022. The market is projected to register a 10.5% CAGR and top a valuation of USD 803.9 Million by 2032.

Increasing prevalence of cardiovascular disorders among the population and the utilization of the reagents across the healthcare industry across the globe is expected to propel the creatine kinase reagent market growth.

Creatine kinase is a cardiac biomarker that alludes to the substances that are released in the bloodstream, owing to heart injury or stress, majorly caused by inadequate blood flow. The quantification of creatine kinase is used for the analysis of various heart situations, such as acute coronary syndrome, acute myocardial infarction, congestive heart failure, ischemia, and others.

Attributes	Details
Creatine Kinase Reagent Market Value in 2022	USD 296.2 Million
Creatine Kinase Reagent Market Value in 2032	USD 803.9 Million
Creatine Kinase Reagent Market CAGR (2022 to 2032)	10.50%

What Are The Major Drivers Boosting The Demand For Creatine Kinase Reagent Market?

The increasing prevalence of cardiovascular disorders among the populace is the major factor propelling the growth of the creatine kinase reagent market. Cardiovascular diseases are one of the major causes of demise, because of the changing and unhealthy lifestyle. Thus, this leads to an increase in the number of patients suffering from cardiovascular disorders and is expected to drive the growth rate of the market in the upcoming years.

Furthermore, the advancements in technology are new opportunities for research and development applications. The budding demand for cardiac testing kits, advanced development of creatine kinase reagents, and the sensitivity and high specificity of the creatine kinase reagents-based tests for accurate and efficient analysis are the aspects that are expected to fuel the market growth during the forecast period.

Moreover, factors such as the increasing geriatric population base, the growing prevalence of an unhealthy lifestyle among people, and unhealthy food and drink consumption, lead to obesity and are the attributes to the rising prevalence of target diseases. This demands the high requirements of ligases that are anticipated to be the major factors driving the market growth.

Which Region Shows Strong Growth Potential In The Creatine Kinase Reagent Market?

North America holds the largest share in the global creatine kinase reagent market owing to the well-established pharmaceutical companies, research institutes, and laboratories in this region. Additionally, the increasing scope of research and development activities in the countries like the USA is expected to accelerate the market during the projected period.

Besides North America, Europe and Asia Pacific regions are also expected to show lucrative growth over the forecast period. The increase in the population suffering from acute myocardial infarction, acute coronary syndrome, and other cardiac disorders is the major factor that is expected to fuel the market growth in Asia Pacific Region.

Who Are The Key Players In The Creatine Kinase Reagent Market?

Some of the key manufacturers operating in the creatine kinase reagent market are BBI Solutions, Abbott, Beckman Coulter, Inc., Boditech Med Inc., DiaSys Diagnostic Systems GmbH, Fujirebio, Novus Biologicals, LLC., PerkinElmer Inc., Pointe Scientific Inc., Randox Laboratories Ltd., and Thermo Fisher Scientific.

Scope Of Report

Report Attributes	Details
Growth Rate	CAGR of 10.5% 2022 to 2032
Base Year for Estimation	2021
Historical Data	2012 to 2021
Forecast Period	2022 to 2032
Qualitative Units	Revenue in USD Billion, Volume in Kilotons, and CAGR from 2022 to 2032
Report Coverage	Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis
Segment Covered	Product, Type, Application, End User, Region
Region Covered	North America; Latin America; Europe; East Asia; South Asia; Oceania; Middle East Africa
Key Countries Profiled	USA, Canada, Brazil, Mexico, Germany, UK, France, Spain, Italy, China, Japan, South Korea, Malaysia, Singapore, Australia, New Zealand, GCC, South Africa, Israel
Key Players	BBI Solutions; Abbott; Beckman Coulter, Inc.; Boditech Med Inc.; DiaSys Diagnostic Systems GmbH; Fujirebio; Novus Biologicals, LLC; PerkinElmer Inc.; Pointe Scientific Inc.; Randox Laboratories Ltd.; Thermo Fisher Scientific
Customization	Available Upon Request

Key Segments Covered In The Creatine Kinase Reagent Industry Survey

By Product:

• Creatine Kinase Reagents
• Creatine Kinase Instruments
• Creatine Kinase Kits

By Type:

• Colorimetric Assay Based Creatine Kinase Tests
• Enzymatic Creatine Kinase Tests
• Point of Care Creatine Kinase Tests
• ELISA-based Creatine Kinase Tests
• Other Creatine Kinase Test Types

By Application:

• Creatine Kinase Reagents for Research Use
• Creatine Kinase Reagents for Diagnosis Use

By End User:

• Creatine Kinase Reagents for Hospitals
• Creatine Kinase Reagents for Clinics
• Creatine Kinase Reagents for Diagnostic Laboratories
• Creatine Kinase Reagents for Academic Research Institutes
• Creatine Kinase Reagents for Other End Users

By Region:

• North America
• Latin America
• Europe
• East Asia
• South Asia Pacific
• The Middle East and Africa (MEA)

Table of Content

• 1. Executive Summary
• 2. Industry Introduction, including Taxonomy and Market Definition
• 3. Market Trends and Success Factors, including Macro-economic Factors, Market Dynamics, and Recent Industry Developments
• 4. Global Market Demand Analysis and Forecast, including Historical Analysis and Future Projections
• 5. Pricing Analysis
• 6. Global Market Analysis and Forecast
  • 6.1. Product
  • 6.2. Type
  • 6.3. Application
  • 6.4. End User
• 7. Global Market Analysis and Forecast, By Product
  • 7.1. Creatine Kinase Reagents
  • 7.2. Creatine Kinase Instruments
  • 7.3. Creatine Kinase Kits
• 8. Global Market Analysis and Forecast, By Type
  • 8.1. Colorimetric Assay Based Creatine Kinase Tests
  • 8.2. Enzymatic Creatine Kinase Tests
  • 8.3. Point of Care Creatine Kinase Tests
  • 8.4. ELISA-based Creatine Kinase Tests
  • 8.5. Other Creatine Kinase Test Types
• 9. Global Market Analysis and Forecast, By Application
  • 9.1. Creatine Kinase Reagents for Research Use
  • 9.2. Creatine Kinase Reagents for Diagnosis Use
• 10. Global Market Analysis and Forecast, By End User
  • 10.1. Creatine Kinase Reagents for Hospitals
  • 10.2. Creatine Kinase Reagents for Clinics
  • 10.3. Creatine Kinase Reagents for Diagnostic Laboratories
  • 10.4. Creatine Kinase Reagents for Academic Research Institutes
  • 10.5. Creatine Kinase Reagents for Other End Users
• 11. Global Market Analysis and Forecast, By Region
  • 11.1. North America
  • 11.2. Latin America
  • 11.3. Europe
  • 11.4. East Asia
  • 11.5. South Asia & Pacific
  • 11.6. The Middle East and Africa (MEA)
• 12. North America Sales Analysis and Forecast, by Key Segments and Countries
• 13. Latin America Sales Analysis and Forecast, by Key Segments and Countries
• 14. Europe Sales Analysis and Forecast, by Key Segments and Countries
• 15. East Asia Sales Analysis and Forecast, by Key Segments and Countries
• 16. South Asia & Pacific Sales Analysis and Forecast, by Key Segments and Countries
• 17. The Middle East and Africa (MEA) Sales Analysis and Forecast, by Key Segments and Countries
• 18. Sales Forecast by Product, Type, Application, and End User for 30 Countries
• 19. Competition Outlook, including Market Structure Analysis, Company Share Analysis by Key Players, and Competition Dashboard
• 20. Company Profile
  • 20.1. Abbott
  • 20.2. Beckman Coulter Inc.
  • 20.3. Boditech Med Inc.
  • 20.4. DiaSys Diagnostic Systems GmbH
  • 20.5. Fujirebio
  • 20.6. Novus Biologicals LLC
  • 20.7. PerkinElmer Inc.
  • 20.8. Pointe Scientific Inc.
  • 20.9. Randox Laboratories Ltd.
  • 20.10. Thermo Fisher Scientific
  • 20.11. Abbott